Filana Therapeutics, Inc. (FLNA)
NCM · Healthcare · Biotechnology
$0.65
-0.89%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$31.6M
Shares Outstanding
48.3M
Exchange
NCM
Currency
USD
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (11.9M) | (14.3M) | (11.2M) | (9.4M) |
| Net Income | (10.8M) | (12.5M) | (10.3M) | (8.6M) |
| Diluted EPS | $-0.22 | $-0.26 | $-0.21 | $-0.18 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (81.5M) | (107.3M) | (142.3M) | (96.1M) |
| Net Income | (76.2M) | (97.2M) | (24.3M) | (91.0M) |
| Diluted EPS | $-1.90 | $-2.32 | $-1.46 | $-1.88 |